Organigram Holdings Stock Total Debt
| OGI Stock | USD 1.52 0.01 0.66% |
OrganiGram Holdings fundamentals help investors to digest information that contributes to OrganiGram Holdings' financial success or failures. It also enables traders to predict the movement of OrganiGram Stock. The fundamental analysis module provides a way to measure OrganiGram Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OrganiGram Holdings stock.
The current Total Debt To Capitalization is estimated to decrease to 0.0004. OrganiGram | Total Debt |
OrganiGram Holdings Company Total Debt Analysis
OrganiGram Holdings' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current OrganiGram Holdings Total Debt | 3.71 M |
Most of OrganiGram Holdings' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OrganiGram Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
OrganiGram Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for OrganiGram Holdings is extremely important. It helps to project a fair market value of OrganiGram Stock properly, considering its historical fundamentals such as Total Debt. Since OrganiGram Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of OrganiGram Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of OrganiGram Holdings' interrelated accounts and indicators.
Click cells to compare fundamentals
OrganiGram Total Debt Historical Pattern
Today, most investors in OrganiGram Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various OrganiGram Holdings' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of OrganiGram Holdings total debt as a starting point in their analysis.
OrganiGram Holdings Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
OrganiGram Net Debt
Net Debt |
|
Based on the latest financial disclosure, OrganiGram Holdings has a Total Debt of 3.71 M. This is 99.87% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The total debt for all United States stocks is 99.93% higher than that of the company.
OrganiGram Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OrganiGram Holdings' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OrganiGram Holdings could also be used in its relative valuation, which is a method of valuing OrganiGram Holdings by comparing valuation metrics of similar companies.OrganiGram Holdings is currently under evaluation in total debt category among its peers.
OrganiGram Holdings Current Valuation Drivers
We derive many important indicators used in calculating different scores of OrganiGram Holdings from analyzing OrganiGram Holdings' financial statements. These drivers represent accounts that assess OrganiGram Holdings' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of OrganiGram Holdings' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 792.0M | 286.6M | 865.7M | 438.7M | 394.8M | 278.1M | |
| Enterprise Value | 794.0M | 365.7M | 815.3M | 373.5M | 336.2M | 278.7M |
OrganiGram Holdings Institutional Holders
Institutional Holdings refers to the ownership stake in OrganiGram Holdings that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of OrganiGram Holdings' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing OrganiGram Holdings' value.| Shares | Two Sigma Advisers, Llc | 2024-06-30 | 101.2 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 49.3 K | Jane Street Group Llc | 2024-06-30 | 48.5 K | Graham Capital Management | 2024-09-30 | 45.4 K | Vontobel Holding Ltd. | 2024-06-30 | 40.6 K | Clear Harbor Asset Management, Llc | 2024-09-30 | 32.8 K | State Of Wyoming | 2024-06-30 | 28.9 K | Hightower Advisors, Llc | 2024-06-30 | 23 K | Pfs Partners, Llc | 2024-09-30 | 19 K | Tidal Investments Llc. | 2024-09-30 | 1.9 M | Renaissance Technologies Corp | 2024-09-30 | 893.4 K |
OrganiGram Fundamentals
| Return On Equity | -0.55 | ||||
| Return On Asset | -0.0556 | ||||
| Profit Margin | (1.54) % | ||||
| Operating Margin | (0.12) % | ||||
| Current Valuation | 109.39 M | ||||
| Shares Outstanding | 108.57 M | ||||
| Shares Owned By Insiders | 31.32 % | ||||
| Shares Owned By Institutions | 9.71 % | ||||
| Number Of Shares Shorted | 2.29 M | ||||
| Price To Earning | (79.96) X | ||||
| Price To Book | 0.78 X | ||||
| Price To Sales | 1.12 X | ||||
| Revenue | 149.21 M | ||||
| Gross Profit | 35.07 M | ||||
| EBITDA | (25.37 M) | ||||
| Net Income | (229.48 M) | ||||
| Cash And Equivalents | 127.36 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 3.71 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 4.17 X | ||||
| Book Value Per Share | 2.85 X | ||||
| Cash Flow From Operations | (35.8 M) | ||||
| Short Ratio | 6.16 X | ||||
| Earnings Per Share | (1.80) X | ||||
| Target Price | 8.8 | ||||
| Number Of Employees | 914 | ||||
| Beta | 1.13 | ||||
| Market Capitalization | 166.96 M | ||||
| Total Asset | 298.45 M | ||||
| Retained Earnings | (538.53 M) | ||||
| Working Capital | 166.34 M | ||||
| Current Asset | 204.52 M | ||||
| Current Liabilities | 54.43 M | ||||
| Net Asset | 298.45 M |
About OrganiGram Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OrganiGram Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OrganiGram Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OrganiGram Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:Check out OrganiGram Holdings Piotroski F Score and OrganiGram Holdings Altman Z Score analysis. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.80) | Revenue Per Share 1.835 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.55) |
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.